Exodus Point Capital Management, LP Celldex Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$32.76 - $42.56 $1.25 Million - $1.62 Million	38,150 New	38,150 $1.41 Million
Q3 2023 Nov 09, 2023	BUY	$25.45 - $37.46 $672,745 - $990,217	26,434 New	26,434 $727,000
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $2.81 Million - $4.79 Million	-135,552 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $567,281 - $1.05 Million	-35,039 Reduced 20.54%	135,552 $2.79 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $2.56 Million - $3.88 Million	170,591 New	170,591 $2.99 Million
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $563,704 - $887,323	-58,415 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $94,048 - $783,345	58,415 New	58,415 $759,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.